United States. Department of Health and Human Services. Office of Inspector General. (2013). FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety. Department of Health and Human Services, Office of Inspector General.
Chicago Style (17th ed.) CitationUnited States. Department of Health and Human Services. Office of Inspector General. FDA Lacks Comprehensive Data to Determine Whether Risk Evaluation and Mitigation Strategies Improve Drug Safety. [Washington, D.C.]: Department of Health and Human Services, Office of Inspector General, 2013.
MLA (9th ed.) CitationUnited States. Department of Health and Human Services. Office of Inspector General. FDA Lacks Comprehensive Data to Determine Whether Risk Evaluation and Mitigation Strategies Improve Drug Safety. Department of Health and Human Services, Office of Inspector General, 2013.